openPR Logo
Press release

Nimodipine Market 2016 - Bayer (Germany), Uquifa (Spain), Shandong Health (China), Ruikang Pharma (China), Kelun Group (China)

11-07-2016 08:31 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Industry Research

Nimodipine Market 2016 - Bayer (Germany), Uquifa (Spain),

Nimodipine (marketed by Bayer as Nimotop) is a dihydropyridine calcium channel blocker originally developed for the treatment of high blood pressure. It is not frequently used for this indication, but has shown good results in preventing a major complication of subarachnoid hemorrhage (a form of cerebral hemorrhage) termed vasospasm.

Major players in the global Nimodipine market :-
Bayer (Germany)
Uquifa (Spain)
Shandong Health (China)
Ruikang Pharma (China)
Kelun Group (China)
Xinhua Pharmaceutical (China)
Yabao Group (China)
Central Pharm (China)

Request for sample @

This report provides detailed analysis of worldwide markets for Nimodipine from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and sub sectors. It covers the key technological and market trends in the Nimodipine market and further lays out an analysis of the factors influencing the supply/demand for Nimodipine, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.

Because it has some selectivity for cerebral vasculature, nimodipine’s main use is in the prevention of cerebral vasospasm and resultant ischemia, a complication of subarachnoid hemorrhage (a form of cerebral bleed), specifically from ruptured intracranial berry aneurysms irrespective of the patient’s post-ictus neurological condition. Its administration begins within 4 days of a subarachnoid hemorrhage and is continued for three weeks. If blood pressure drops by over 5%, dosage is adjusted. There is still controversy regarding the use of intravenous nimodipine on a routine basis.

A 2003 trial (Belfort et al.) found nimodipine was inferior to magnesium sulfate in preventing seizures in women with severe preeclampsia. Nimodipine is not regularly used to treat head injury. Several investigations have been performed evaluating its use for traumatic subarachnoid hemorrhage; a systematic review of 4 trials did not suggest any significant benefit to the patients that receive nimodipine therapy.

Read full report with TOC :

Global Nimodipine Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Nimodipine market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players.

The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Nimodipine industry has been provided.

"MarketInsights.Biz” offer reports from top publishers and update to serve you with immediate on-line access to professional insights on global industries, companies, products, and trends. Customers can buys different reports across various categories such as Chemical and Material, Biotechnology, Healthcare, Food and beverages, Automobile and various sectors. Our Website offers safe and secure online ordering experience, convenient payment options.

Contact US:

Frank Valadez
Director of Business Development
Website: http://marketinsights.biz/
Email:sales@marketinsights.biz

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Nimodipine Market 2016 - Bayer (Germany), Uquifa (Spain), Shandong Health (China), Ruikang Pharma (China), Kelun Group (China) here

News-ID: 379767 • Views:

More Releases from Industry Research

Spinal Cord Stimulation Devices Market Report 2019 with Universal Growth Analysi …
Global "Spinal Cord Stimulation Devices" Market Report gives complete framework data on market definition, research methodology, current scenario, dynamics, major conclusions, market Segmentation by technology, product types, application and geography. Spinal Cord Stimulation Devices market report also covers a study on the competitive landscape which describes mergers and acquisition. And also provides analysis on agreements, collaborations, and partnerships between leading key players in Spinal Cord Stimulation Devices market growth. Get a
Global Artificial Intelligence Platforms Market Size & Outlook 2023: Details for Business Development, Regions, Key Players, Opportunities
Global Artificial Intelligence Platforms Market Size & Outlook 2023: Details for …
Global “Artificial Intelligence Platforms Market” report offers a specified analysis of the different patterns and parameters affecting the development of the global Artificial Intelligence Platforms market. The report also delivers an assessment of the effect of the current patterns in the market including the other essential information about the market’s future development. The report comprises detailed information relating to the growth factors of the Artificial Intelligence Platforms market and also
Compact Type Spark Plugs Market Analysis, Growth, Industry Outlook and Forecast Report 2019
Compact Type Spark Plugs Market Analysis, Growth, Industry Outlook and Forecast …
The Global “Compact Type Spark Plugs Market” Report presents a strong perspective on market size, market scope, and competitive environment for conclusions and research. This study is derived from primary and secondary statistical data and includes qualitative and numerical analysis. Compact Type Spark Plugs market research focuses on the key influences prevailing in the global Compact Type Spark Plugs industry. An existing Compact Type Spark Plugs market scenario has been
Surgical Aspiration & Irrigation Suction Pumps Market In-Depth Analysis – By Market Size, Type and Application 2019-2024
Surgical Aspiration & Irrigation Suction Pumps Market In-Depth Analysis – By M …
The Global “Surgical Aspiration & Irrigation Suction Pumps Market” Report presents a strong perspective on market size, market scope, and competitive environment for conclusions and research. This study is derived from primary and secondary statistical data and includes qualitative and numerical analysis. Surgical Aspiration & Irrigation Suction Pumps market research focuses on the key influences prevailing in the global Surgical Aspiration & Irrigation Suction Pumps industry. An existing Surgical Aspiration

All 5 Releases


More Releases for Nimodipine

Nimodipine Sustained Release Tablets Market Set for Exceptional Growth from 2024 …
The Nimodipine Sustained Release Tablets Market 2024-2023 report provides a comprehensive analysis of Types (30mg/Piece, 60mg/Piece, Others), Application (Hospital, Pharmacy, Others), Analysis of Industry Trends, Growth, and Opportunities, R&D landscape, Data security and privacy concerns Risk Analysis, Pipeline Products, Assumptions, Research Timelines, Secondary Research and Primary Research, Key Insights from Industry Experts, Regional Outlook and Forecast, 2024-2032. Major Players of Nimodipine Sustained Release Tablets Market are: Bionpharma, Arbor Pharmaceuticals, Sofgen Pharmaceuticals, Pharmaceutics International,
Nimodipine Market Size, Share, Growth, Trends, Analysis and Forecast - 2031
Nimodipine, a calcium channel blocker initially manufactured and marketed for the treatment of hypertension, is also used in preventing vasospasm secondary to subarachnoid hemorrhage (a type of cerebral hemorrhage). Nimodipine comes under the brand called Nimotop. The global Nimodipine market is expected to grow at a CAGR of during the forecast period 2024-2031. Get Free Sample link @ https://www.omrglobal.com/request-sample/nimodipine-market The prominent Nimodipine market players operating globally include Bionpharma, Sun Pharm Inds, Sofgen
Nimodipine Market to Witness Robust Expansion by 2029
Nimodipine Market, a calcium channel blocker initially manufactured and marketed for the treatment of hypertension, is also used in preventing vasospasm secondary to subarachnoid hemorrhage (a type of cerebral hemorrhage). Nimodipine comes under the brand called Nimotop. The global Nimodipine market is expected to grow at a CAGR of xx% during the forecast period. The prominent Nimodipine market players operating globally include Bionpharma, Sun Pharm Inds, Sofgen pharms, Arbor Pharms, Bayer
Nimodipine Market Insights: Demand, Opportunities, and Competitive Landscape
Allied Market Research Analyst have added a new research study on Title Nimodipine Market, Global Outlook and Forecast 2023-2030 with detailed information & Key Players Such as Sofgen Pharmaceuticals, Heritage Pharma Labs, Sun Pharmaceutical, ThePharmaNetwork, Bayer Vital, Arbor Pharmaceuticals, LUSOCHIMICA, Shandong Xinhua, Bionpharma, Omicron Pharma. The Study provides in-depth comprehensive analysis includes Clear Market definitions, classifications, manufacturing processes, cost structures, development policies and plans. The facts and data are well
Nimodipine Market Aims to Expand at Double-Digit Growth Rate | Sofgen Pharms, He …
This Nimodipine market research performs systematic analysis of the market to provide profound perceptions, determine market situation and potent advancements and track prior market performances. There were several industries got shutdown due to the COVID-19 plague. This market report captures the considerable losses that businesses got and even guides them how to come out of this pandemic situation. As this pandemic left several adverse effects on different business sectors,
Nimodipine Market is Booming Worldwide (2020-2026)-Says QYResearch | , Sun Pharm …
LOS ANGELES, United States: QY Research has recently published a research report titled, “Global Nimodipine Market Research Report 2020". This report has been prepared by experienced and knowledgeable market analysts and researchers. It is a phenomenal compilation of important studies that explore the competitive landscape, segmentation, geographical expansion, and revenue, production, and consumption growth of the global Nimodipine market. Players can use the accurate market facts and figures and statistical